ATE321764T1 - Tetracyclische heteroverbindungen als modulatoren des östrogenrezeptors - Google Patents
Tetracyclische heteroverbindungen als modulatoren des östrogenrezeptorsInfo
- Publication number
- ATE321764T1 ATE321764T1 AT02797167T AT02797167T ATE321764T1 AT E321764 T1 ATE321764 T1 AT E321764T1 AT 02797167 T AT02797167 T AT 02797167T AT 02797167 T AT02797167 T AT 02797167T AT E321764 T1 ATE321764 T1 AT E321764T1
- Authority
- AT
- Austria
- Prior art keywords
- heter
- tetracyclic
- modulators
- compounds
- estrogen receptor
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 102000015694 estrogen receptors Human genes 0.000 title 1
- 108010038795 estrogen receptors Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Gynecology & Obstetrics (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34195701P | 2001-12-19 | 2001-12-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE321764T1 true ATE321764T1 (de) | 2006-04-15 |
Family
ID=23339719
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02797167T ATE321764T1 (de) | 2001-12-19 | 2002-12-02 | Tetracyclische heteroverbindungen als modulatoren des östrogenrezeptors |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1467998B1 (de) |
| JP (1) | JP2005513133A (de) |
| CN (1) | CN1620457A (de) |
| AR (1) | AR038661A1 (de) |
| AT (1) | ATE321764T1 (de) |
| AU (1) | AU2002362041A1 (de) |
| BR (1) | BR0215152A (de) |
| CA (1) | CA2471107A1 (de) |
| CY (1) | CY1105361T1 (de) |
| DE (1) | DE60210333T2 (de) |
| DK (1) | DK1467998T3 (de) |
| ES (1) | ES2264737T3 (de) |
| HU (1) | HUP0500103A3 (de) |
| IL (1) | IL162295A0 (de) |
| MX (1) | MXPA04006034A (de) |
| NZ (1) | NZ533281A (de) |
| PL (1) | PL371045A1 (de) |
| PT (1) | PT1467998E (de) |
| RU (1) | RU2305099C2 (de) |
| WO (1) | WO2003053977A1 (de) |
| ZA (1) | ZA200405653B (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7329654B2 (en) * | 2001-12-19 | 2008-02-12 | Janssen Pharmaceutica N.V. | Heteroatom containing tetracyclic derivatives as selective estrogen receptor modulators |
| US7105679B2 (en) | 2001-12-19 | 2006-09-12 | Kanojia Ramesh M | Heteroatom containing tetracyclic derivatives as selective estrogen receptor modulators |
| US8614204B2 (en) | 2003-06-06 | 2013-12-24 | Fibrogen, Inc. | Enhanced erythropoiesis and iron metabolism |
| EP1713820A1 (de) * | 2004-01-22 | 2006-10-25 | Eli Lilly And Company | Selektive östrogen-rezeptor-modulatoren |
| AU2005300030B2 (en) | 2004-09-20 | 2012-01-12 | Janssen Pharmaceutica N.V. | Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators |
| MX2007016160A (es) | 2005-06-15 | 2008-03-07 | Fibrogen Inc | Uso de moduladoers de hif-1 alfa para el tratamiento contra el cancer. |
| DE102006024032A1 (de) * | 2006-05-23 | 2007-11-29 | Voith Patent Gmbh | Anordnung zur Bandregelung |
| RU2360670C1 (ru) * | 2007-10-03 | 2009-07-10 | Закрытое акционерное общество "Биологические исследования и системы" | Фармацевтическая композиция для местного и наружного применения при климактерических расстройствах на основе сигетина |
| RS56042B1 (sr) * | 2010-06-10 | 2017-09-29 | Seragon Pharmaceuticals Inc | Modulatori estrogenih receptora i njihove upotrebe |
| WO2013090829A1 (en) * | 2011-12-14 | 2013-06-20 | Aragon Pharmaceuticals, Inc. | Estrogen receptor modulators and uses thereof |
| CN113135884B (zh) * | 2020-01-20 | 2023-03-10 | 西华大学 | 一种异色烯类化合物及其制备方法和用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL124481C (de) * | 1964-11-04 | |||
| SU1607348A1 (ru) * | 1989-03-02 | 1994-09-30 | Пятигорский фармацевтический институт | 7-(3-фенилпропеноилокси)- 4' -фторизофлавон, обладающий гипотензивным действием |
| CA2214196A1 (en) * | 1996-09-26 | 1998-03-26 | Eli Lilly And Company | Benzo[b]indeno[2,1-d]thiophene compounds, intermediates, processes, compositions and methods |
| US6153768A (en) * | 1996-12-13 | 2000-11-28 | C & C Research Laboratories | Benzopyran derivatives |
| RU2138669C1 (ru) * | 1997-07-02 | 1999-09-27 | Гнедых Александр Михайлович | Воздушный ракетный двигатель |
-
2002
- 2002-12-02 EP EP02797167A patent/EP1467998B1/de not_active Expired - Lifetime
- 2002-12-02 JP JP2003554693A patent/JP2005513133A/ja not_active Withdrawn
- 2002-12-02 AU AU2002362041A patent/AU2002362041A1/en not_active Abandoned
- 2002-12-02 AT AT02797167T patent/ATE321764T1/de not_active IP Right Cessation
- 2002-12-02 IL IL16229502A patent/IL162295A0/xx unknown
- 2002-12-02 DE DE60210333T patent/DE60210333T2/de not_active Expired - Fee Related
- 2002-12-02 HU HU0500103A patent/HUP0500103A3/hu unknown
- 2002-12-02 PT PT02797167T patent/PT1467998E/pt unknown
- 2002-12-02 RU RU2004118606/04A patent/RU2305099C2/ru not_active IP Right Cessation
- 2002-12-02 ES ES02797167T patent/ES2264737T3/es not_active Expired - Lifetime
- 2002-12-02 CN CNA028281446A patent/CN1620457A/zh active Pending
- 2002-12-02 CA CA002471107A patent/CA2471107A1/en not_active Abandoned
- 2002-12-02 BR BR0215152-9A patent/BR0215152A/pt not_active IP Right Cessation
- 2002-12-02 PL PL02371045A patent/PL371045A1/xx not_active Application Discontinuation
- 2002-12-02 NZ NZ533281A patent/NZ533281A/en unknown
- 2002-12-02 MX MXPA04006034A patent/MXPA04006034A/es active IP Right Grant
- 2002-12-02 DK DK02797167T patent/DK1467998T3/da active
- 2002-12-02 WO PCT/US2002/038486 patent/WO2003053977A1/en not_active Ceased
- 2002-12-18 AR ARP020104957A patent/AR038661A1/es unknown
-
2004
- 2004-07-15 ZA ZA200405653A patent/ZA200405653B/xx unknown
-
2006
- 2006-06-08 CY CY20061100768T patent/CY1105361T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2471107A1 (en) | 2003-07-03 |
| ES2264737T3 (es) | 2007-01-16 |
| HUP0500103A3 (en) | 2009-01-28 |
| EP1467998B1 (de) | 2006-03-29 |
| JP2005513133A (ja) | 2005-05-12 |
| MXPA04006034A (es) | 2005-03-31 |
| BR0215152A (pt) | 2004-10-19 |
| AR038661A1 (es) | 2005-01-26 |
| PL371045A1 (en) | 2005-06-13 |
| NZ533281A (en) | 2007-05-31 |
| DE60210333T2 (de) | 2006-11-30 |
| WO2003053977A1 (en) | 2003-07-03 |
| CN1620457A (zh) | 2005-05-25 |
| DE60210333D1 (de) | 2006-05-18 |
| RU2004118606A (ru) | 2006-01-10 |
| HK1068875A1 (en) | 2005-05-06 |
| DK1467998T3 (da) | 2006-07-31 |
| CY1105361T1 (el) | 2010-03-03 |
| AU2002362041A1 (en) | 2003-07-09 |
| PT1467998E (pt) | 2006-08-31 |
| RU2305099C2 (ru) | 2007-08-27 |
| EP1467998A1 (de) | 2004-10-20 |
| IL162295A0 (en) | 2005-11-20 |
| HUP0500103A2 (hu) | 2005-05-30 |
| ZA200405653B (en) | 2006-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE497953T1 (de) | Thiazolderivate als modulatoren des cannabinoidrezeptors | |
| ATE277933T1 (de) | Thiophenverbindungen zur verwendung als antikrebsmittel | |
| DE60327767D1 (de) | Tricyclische steroidhormonkernrezeptor-modulatoren | |
| ATE333449T1 (de) | 1,2,4-thiadiazoliumverbindungen als melanocortinrezeptor-modulatoren | |
| ATE344254T1 (de) | 1,2,4-thiadiazolverbindungen als melanocortinrezeptor-modulatoren | |
| EE200200082A (et) | Uued spiroühendid | |
| DE60013803D1 (de) | Tetracyclische azepinoindol verbindungen als 5-ht rezeptor liganden | |
| ATE268776T1 (de) | Benzodiazepinderivate als gaba-a- rezeptormodulatoren | |
| ATE253067T1 (de) | Diazabicyloderivate als nikotin-acetylcholin- rezeptorliganden | |
| DE60102233D1 (de) | Triazolyltropanderivate als ccr5-modulatoren | |
| ATE420881T1 (de) | Kondensierte heterocyclische verbindungen als modulatoren des serotoninrezeptors | |
| ATE283857T1 (de) | Imidazo(1,5-aöpyrimido)5,4-döbenz azepinderivate als gaba-a-rezeptormodulatoren | |
| DE602004014772D1 (de) | Pyrrol-2,5-dithionderivate als modulatoren des liver-x-rezeptors | |
| AU2003256922A8 (en) | Substituted heterocyclic compounds as modulators of the ccr5 receptor | |
| ATE321764T1 (de) | Tetracyclische heteroverbindungen als modulatoren des östrogenrezeptors | |
| ATE529419T1 (de) | Chromanderivate als estrogene verbindungen | |
| DE602004014773D1 (de) | Pyrrol-2,5-dionderivate als modulatoren des liver-x-rezeptors | |
| DE50206096D1 (de) | Substituierte benzoäbüazepin-2-on-verbindungen als schmerzmittel | |
| EP1755603A4 (de) | 3,3-disubstituierte tetrahydropyranyl cyclopentyl amide modulatoren der chemokin-rezeptor-aktivität | |
| ATE244716T1 (de) | Neue n-triazolylmethyl-piperazinderivate als neurokininrezeptor-antagonisten | |
| DK1404673T3 (da) | Teknisk syntesefremgangsmåde til fremstilling af tropenol | |
| DE60201463D1 (de) | Indanon-Derivate als Duftstoffe | |
| DE60211116D1 (de) | Ausgleichsmechanismus | |
| ATE405569T1 (de) | Pentacyclische taxan-verbindungen | |
| PT1175417E (pt) | Compostos substituidos de benzolactamas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1467998 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |